Sylvain El Khoury

Dr. Sylvain El Khoury


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in The Ocular Surface
Verified
Journal Article
Closed access
SSSami Saad
Sami Saad
YAYoussef Abdelmassih
Youssef Abdelmassih
RSRana Saad
Rana Saad
DGDamien Guindolet
Damien Guindolet
SKSylvain El Khoury
Sylvain El Khoury
EGEric E. Gabison
Eric E. Gabison

1 August 2016 in Journal of Refractive Surgery
Verified
Journal Article
Closed access
SKSylvain El Khoury
Sylvain El Khoury
YAYoussef Abdelmassih
Youssef Abdelmassih
AHAdib Hamade
Adib Hamade
ESElise Slim
Elise Slim
CCCarole G. Cherfan
Carole G. Cherfan
EJElias F. Jarade
Elias F. Jarade
PURPOSE: To report the incidence, clinical presentation, risk factors, and treatment outcome of pediatric keratoconus in a tertiary referral eye hospital in Beirut, Lebanon. METHODS: In this retrospective study, the authors evaluated all patients with keratoconus 14 years or younger newly diagnosed at the Beirut Eye Specialist Hospital, Beirut, Lebanon, between January 2010 and December 2014. The incidence of pediatric keratoconus among all pediatric patients and among patients with keratoconus of all ages was assessed. Patients with pediatric keratoconus were evaluated for keratoconus stage, initial presentation, uncorrected distance visual acuity, corrected distance visual acuity (CDVA), corneal topography, and pachymetry. Patients were classified according to different treatment regimen groups and different follow-up visits were evaluated. RESULTS: During 5 years, 16,808 patients were examined, of whom 2,972 were 14 years or younger. A total of 541 patients were diagnosed as having keratoconus; of those, 16 were 14 years or younger at the time of diagnosis. Hence, the incidence of keratoconus was 0.53% among pediatric patients and 3.78% among adult patients (> 14 years). Initial presentation was during routine checkup (1 of 16) for allergic conjunctivitis (3 of 16), reduced vision (10 of 16), and corneal hydrops (mimicking keratitis) (2 of 16). Except for 2 patients lost to follow-up, all eyes received corneal cross-linking treatment and 16 eyes received additional intracorneal ring segment implantation. CONCLUSIONS: The incidence of pediatric keratoconus indicates that increased awareness for keratoconus among children is needed, mainly in cases of family history of keratoconus, ocular allergy/pruritus, poor CDVA, corneal hydrops, and/or high astigmatism. [ J Refract Surg . 2016;32(8):534–541.]

1 September 2017 in Journal of Refractive Surgery
Verified
Journal Article
Closed access
YAYoussef Abdelmassih
Youssef Abdelmassih
SKSylvain El Khoury
Sylvain El Khoury
ECElias Chelala
Elias Chelala
ESElise Slim
Elise Slim
CCCarole G. Cherfan
Carole G. Cherfan
EJElias Jarade
Elias Jarade
PURPOSE: To evaluate 6-month and 2-year safety and clinical outcomes of Visian toric Implantable Collamer Lens (toric ICL) (STAAR Surgical, Monrovia, CA) implantation for the treatment of residual refractive errors after sequential intracorneal ring segments (ICRS) insertion and cross-linking (CXL) in keratoconus.METHODS: This consecutive case series included the results of a three-step ICRS–CXL–toric ICL procedure in 16 eyes of 13 patients with moderate to severe keratoconus (stages II and III of Amsler–Krumeich classification). The ICRS and CXL procedures were performed sequentially with an interval of 4 weeks and the toric ICL implantation was performed at least 6 months after CXL. Data were collected preoperatively, at 6 months after sequential ICRS–CXL, and at 6 and 24 months following toric ICL implantation. All 16 eyes were evaluated at the 2-year follow-up.RESULTS: There was a significant decrease in keratometry (steep, flat, and maximum) and refraction (sphere and spherical equivalence, but not cylinder) and a significant increase in both uncorrected (UDVA) (from 1.06 to 0.76 logMAR,P= .004) and corrected (CDVA) (from 0.42 to 0.26 logMAR;P= .002) distance visual acuity 6 months following sequential ICRS–CXL, whereas UDVA and refraction significantly improved 6 months after ICL insertion (UDVA reached 0.33 logMAR,P= .001). At the 24-month follow-up, UDVA and keratometric readings were stable, whereas CDVA, sphere, and cylinder showed a significant improvement.CONCLUSIONS: Implantation of Visian toric ICL following sequential ICRS insertion and CXL is an effective and safe option for correcting high residual refractive error and improving visual acuity in patients with moderate to severe keratoconus in the long term.[J Refract Surg.2017;33(9):610–616.]

1 June 2017 in American Journal of Ophthalmology
Verified
Journal Article
Closed access
YAYoussef Abdelmassih
Youssef Abdelmassih
SKSylvain El Khoury
Sylvain El Khoury
ADAli Dirani
Ali Dirani
RARafic Antonios
Rafic Antonios
AFAli Fadlallah
Ali Fadlallah
EJElias F. Jarade
Elias F. Jarade

26 September 2018 in Acta Ophthalmologica
Verified
Journal Article
Closed access
PDF file
NFNicolas Famery
Nicolas Famery
YAYoussef Abdelmassih
Youssef Abdelmassih
SKSylvain El Khoury
Sylvain El Khoury
DGDamien Guindolet
Damien Guindolet
ICIsabelle Cochereau
Isabelle Cochereau
EGEric E. Gabison
Eric E. Gabison

26 February 2019 in Cornea
Verified
Journal Article
Closed access
YAYoussef Abdelmassih
Youssef Abdelmassih
PDPierre Dubrulle
Pierre Dubrulle
CSCharles Sitbon
Charles Sitbon
SKSylvain El Khoury
Sylvain El Khoury
DGDamien Guindolet
Damien Guindolet
EGEric E. Gabison
Eric E. Gabison
Purpose: To describe the functional outcome, postoperative complications, and complication management of Descemet's membrane endothelial keratoplasty (DMEK) in corneal decompensation secondary to Herpes simplex eye disease (HED). Methods: This retrospective interventional case series included 17 eyes that received DMEK for endothelial decompensation secondary to HED. Complete ophthalmological examination, including corrected-distance visual acuity (CDVA), anterior segment slit-lamp, and optical coherence tomography assessment, were performed preoperatively and postoperatively at regular follow-up intervals. Visual outcome and complication rates were compared with those of 72 consecutive eyes that received DMEK for Fuchs endothelial corneal dystrophy (FECD) and pseudophakic bullous keratopathy (PBK) during the same period. Results: Mean follow-up time was 11.1 ± 5.9 months (range 6–27). CDVA improved from 1.16 ± 0.46 logMAR to 0.62 ± 0.44 logMAR (P = 0.001). Corneal pachymetry significantly decreased from 695 ± 53 μm at day 1 to 569 ± 88 μm at 2 months (P < 0.001). Postoperative complications occurred in 12 eyes, including primary graft failure (12%), endotheliitis (29%), corneal ulcers (35%), and cystoid macular edema (18%). Most complications occurred shortly after surgery, with a median delay of 2.5 months. In comparison, the complication rates for DMEK in FECD and PBK were significantly lower (no graft failure, P = 0.005; no endotheliitis, P < 0.001; no corneal ulcers, P < 0.001 and 3% cystoid macular edema, P = 0.046). Conclusions: DMEK surgery significantly improved CDVA in patients with endothelial decompensation due to HED. The rate of postoperative complications was higher than for FECD and PBK. Close follow-up is mandatory and the rate of postoperative inflammatory events suggests that patients should be kept on high doses of oral valacyclovir.